— Cash runway extended into 2026 —
— Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million —
— Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and norovirus programs —
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.